Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye
NCT00471419
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
750
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye
Interventions
DRUG:
Rimexolone
Sponsor
Alcon Research